tert-Butyl 4-(1H-1,3-benzodiazol-2-yl)piperidine-1-carboxylate

GTC-619

Pharmaceutical Intermediates

tert-Butyl 4-(1H-1,3-benzodiazol-2-yl)piperidine-1-carboxylate

CAS No.
953071-73-3
Catalogue ID
GTC-619

tert-Butyl 4-(1H-1,3-benzodiazol-2-yl)piperidine-1-carboxylate, CAS 953071-73-3. Source-derived identification, physical data and applications are provided for catalogue reference; request the current specification, COA and SDS for the required grade.

Catalogue aliases / related identifiers

tert-Butyl 4-(1H-benzimidazol-2-yl)piperidine-1-carboxylate; Bilastine Impurity; Pilastine impurity 18; tert-butyl 4-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate

Supplied catalogue source: GTC-619 · Page 99

Reference data — confirm before ordering or use

The information below is a structured migration from the supplied catalogue snapshot. It is not a current product specification, COA or SDS. Confirm the actual supplier, grade, batch documents, classification, packing and destination requirements for your enquiry.


Basic Information

CAS No.953071-73-3
EC No.Not available
Linear FormulaC17H23N3O2
Molecular Weight301.38
AppearanceWhite to off-white solid
Melting PointNot available (typical reference)
Boiling point497 ± 38 °C (predicted, lit.)
DensityNot available (typical reference)
SolubilitySoluble in organic solvents such as DMSO, methanol, and dichloromethane; limited solubility in water
Storage ConditionsSealed in dry container at 2-8°C, protected from light and moisture
Chemical StructureMolecular Structure of tert-Butyl 4-(1H-1,3-benzodiazol-2-yl)piperidine-1-carboxylate

Key Applications

  • Pharmaceutical intermediate: A key protected intermediate in pathways associated with bilastine and related antihistamine compound synthesis, and an important component within Bilastine and specialty antihistamine intermediates for pharmaceutical development.

  • API intermediate: Facilitates incorporation of the benzimidazole-piperidine motif into active pharmaceutical ingredients after deprotection, making it relevant to piperazine and piperidine intermediates in API synthesis.

  • Heterocyclic synthesis: Provides a Boc-masked piperidine linked to benzimidazole for constructing fused heterocyclic frameworks, especially among quinazolinone, benzimidazole and fused heterocycle intermediates.

  • Medicinal chemistry research: Utilized in analog design and structure modification studies targeting therapeutic scaffolds and related antihistamine discovery programs.

  • Process development: Supports evaluation of deprotection conditions and scale-up strategies for pharmaceutical manufacturing routes and pharmaceutical intermediates for API synthesis.


  • Consistent product quality: High purity maintained with batch-specific analytical data to ensure suitability for precise synthetic applications.

  • Stable global supply: Proven logistics framework guarantees on-time delivery across laboratory to pilot-scale requirements worldwide.

  • SDS and COA support: SDS, COA, and related certificates supplied readily to assist with quality assessment and compliance procedures.

  • Packaging and technical service: Flexible packaging choices like 1kg, 5kg, or 25kg in fiber drums with PE liners, paired with attentive technical support.

Before you order

Confirm the current commercial product record.

Include the required grade or purity, quantity, preferred packing, destination country/port and required document set.

  • 01Current specification
  • 02Batch or sample COA
  • 03Product- and supplier-specific SDS
  • 04Packing and shipping review
Request product review

INQUIRY

INQUIRY